Ng Michelle, Heckl Dirk, Klusmann Jan-Henning
Department of Pediatrics I, Martin Luther University Halle-Wittenberg, Halle, Germany.
Front Oncol. 2019 Jul 9;9:570. doi: 10.3389/fonc.2019.00570. eCollection 2019.
In this post-genomic era, long noncoding RNAs (lncRNAs) are rapidly gaining recognition for their crucial roles across diverse biological processes and contexts. The human blood system is no exception, where dozens of lncRNAs have been established as regulators of normal and/or malignant hematopoiesis, and where ongoing works continue to uncover novel lncRNA functions. Our review focuses on lncRNAs that are involved in the pathogenesis of acute myeloid leukemia (AML) and the mechanisms through which they control gene expression in this disease context. We also comment on genome-wide sequencing or profiling studies that have implicated large sets of lncRNAs in AML pathophysiology.
在这个后基因组时代,长链非编码RNA(lncRNAs)因其在各种生物过程和环境中的关键作用而迅速获得认可。人类血液系统也不例外,数十种lncRNAs已被确认为正常和/或恶性造血的调节因子,并且相关研究仍在不断揭示lncRNA的新功能。我们的综述聚焦于参与急性髓系白血病(AML)发病机制的lncRNAs,以及它们在这种疾病背景下控制基因表达的机制。我们还对全基因组测序或分析研究进行了评论,这些研究表明大量lncRNAs与AML的病理生理学有关。